Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Covid 19: Will pain-free, at-home screening tests be our salvation?

The world’s best defence against the spread of COVID-19 in 2021 will not be a vaccine, medical experts now say. Instead, it will be the widespread adoption of cheap, non-invasive diagnostic detection devices for coronaviruses – ones that look and function...
Marc Davis | September 1, 2020 |

The Euro Bulls Appear Really Short of Breath

We’re seeing some nice moves in the currencies today. After a couple of days hesitating, the euro has made a profitable move lower. The loonie bulls aren’t making much headway either. Today is simply a risk-off day. In days like this, it&CloseCu...
Nadia Simmons | May 15, 2019 |

The Bulls Still Appear Short of Breath. And Quote a Lot So.

It turned out that the oil bulls haven’t had much success yesterday either. And today isn’t shaping up to be a much better day for them either. Yet, they have taken black gold higher from its daily lows already – does this mark some kind of a tu...
Nadia Simmons | August 23, 2019 |

G2 Energy gears up for a turnaround with a growing oil production portfolio

Over and over again, you hear the same story: “The energy transition is underway and renewables are going to replace fossil fuels!“ In the next breath, you wonder why the IEA, and others, are projecting record oil demand for this year – and that oil demand wil...
Research | May 9, 2023 |

S&P 500 Index Must Bounce Here Or Hold Your Breath!

The fragility of the markets can not be underestimated for investors at this time. Our research has continued to pick apart these price swings in the US stock markets and our July predictions regarding a market top and an August 19 th (or near) breakdown price move ...
Chris Vermeulen | August 26, 2019 |

Aging in the New World Order of Managed Markets

After over 40 years in the world of money and markets, I have arrived at the conclusion that aging can be a double-edged sword where the advantages created by many years of experience are many times odiously offset by innate biases that become ingrained over time. It came...
Streetwise Reports | March 22, 2019 |

PCR Testing: XPhyto Disrupts a Blockbuster Business

It’s the technological evolution that could transform the US $84.4 billion Covid-19 diagnostics market. Vancouver-based life sciences company XPhyto Therapeutics Corp. (CSE: XPHY) (FSE: 4XT) (OTC: XPHYF) expects its rapid Covid-19 test system to be approv...
Marc Davis | February 25, 2021 |

Analyst Stress Tests Sustainability of Occidental Petroleum's Common Dividend

The methods and findings of this analysis are presented in a Raymond James report. In a May 22 research note, Raymond James analyst Pavel Molchanov reported that Occidental Petroleum Corp.'s (OXY:NYSE) current "lofty" dividend yield could be the market sig...
Streetwise Reports | May 28, 2019 |

AIM ImmunoTech Shares Soar as Japan's NIID Tests Ampligen® as Potential Coronavirus Treatment

Shares of AIM ImmunoTech traded more than 150% higher after the company reported that Japan's National Institute of Infectious Diseases will test its Ampligen® drug as a potential treatment for the coronavirus. Immuno-pharmaceutical company AIM Imm...
Streetwise Reports | March 10, 2020 |

Buzz on the Bullboards: COVID-19 Testing Plays

There are many investing plays that are attractive to serious investors and small-cap opportunists in the current market, but coronavirus movements take the cake. We’ve noted that each sector has its share of positive opportunities for both long-term and sh...
Omri Wallach | May 6, 2020 |
1 2 3 4 5 6 7 8 9 10 ...